The European Medicines Agency (EMA) has launched a probe into the highly controversial HPV vaccination program following thousands of reports of young girls falling seriously ill after getting jabbed. Per the Swedish news sourceSvenska Dagbladet (SvD), the European Union’s version of the Food And Drug Administration (FDA) launched the investigation to determine whether or not the safety claims associated with Gardasil and Cervarix, the two HPV vaccines currently in circulation, are actually legitimate.
The multinational drug corporations behind the two vaccines, Merck & Co. and GlaxoSmithKline (GSK), respectively, say the vaccines are perfectly safe and come with minimal risk of side effects. But the many thousands of young girls throughout the world who’ve suffered serious side effects, including several hundred recently featured in a Danish documentary that aired on Denmark’s TV2 network, claim otherwise, reporting major health failures almost immediately following the jab.
HPV vaccines have already been administered to some 70 million women worldwide, but their safety and effectiveness is questionable at best. The science used to justify their commercial approval simply doesn’t stand up to scrutiny, and yet many countries throughout the world have adopted HPV vaccines as a preventative medicine for preventing cervical cancer.
Canadian researchers published a study in 2013 revealing that the industry-sponsored trials used to justify commercial approval of HPV vaccines are “largely inadequate” and present “evidence of selective reporting of results from clinical trials,” meaning vaccinecompanies cherry-pick data to suit their own agenda.
“[T]he widespread optimism regarding HPV vaccines long-term benefits appears to rest on a number of unproven assumptions (or such which are at odd with factual evidence) and significant misinterpretation of available data,” the team wrote.
“For example, the claim that HPV vaccination will result in approximately 70% reduction of cervical cancers is made despite the fact that the clinical trials data have not demonstrated to date that the vaccines have actually prevented a single case of cervical cancer (let alone cervical cancer death), nor that the current overly optimistic surrogate marker-based extrapolations are justified.”
Of particular interest to the EMA in its investigation are the many reports of postural orthostatic tachycardia syndrome, or POTS, following vaccination for HPV. POTS victims say that since getting vaccinated, they’re only able to function for a few hours a day, which inhibits not only their quality of life but also their schooling.
“POTS … can cause an array of symptoms, including headache, dizziness, fainting, and fatigue,” reports SvD.
Another serious condition being reported in conjunction with the HPV vaccines is complex regional pain syndrome, or CRPS, which sufferers say causes them to experience chronic and severe pain in their legs, arms, or both. Both of these conditions are listed in HPV vaccine literature as being possible side effects, but vaccine manufacturers deny that they’re a risk factor.
“In a nutshell, we can conclude that there is limited evidence of some effectiveness of the HPV vaccine, but this effectiveness is probably substantially lower than that which health authorities claim,” reports the Alliance for Natural Health – Europe. “Complicating the picture is that the government take on adverse events appears to understate the seriousness of adverse reactions.”
Be sure to review the full ANH-Europe report on HPV vaccines here: anh-europe.org